Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SWEN Capital Partners is a leading European investment firm specializing in sustainable private equity and venture capital. Headquartered in Paris, the firm manages over €8 billion in assets and integrates rigorous environmental, social, and governance (ESG) criteria across its investment strategies. SWEN maintains a significant presence in the healthcare and life sciences sectors, providing venture and growth capital to innovative biotech, medtech, and digital health companies. Their investment approach focuses on supporting transformative technologies that address significant unmet medical needs while promoting sustainable development. The firm operates as a joint venture between OFI Invest and Arkéa Investment Management, leveraging deep institutional expertise to foster the growth of its portfolio companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Swen Capital Partners.